Naloxone Hydrochloride Spray
Product Images NDC 71205-707

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 71205-707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (a) (2y2 Figure 1 (a))

A line graph showing naloxone plasma concentration (ng/mL) over time (hours postdose) for different naloxone hydrochloride nasal spray doses and an intramuscular injection. The graph compares concentrations for 2 mg and 4 mg nasal sprays in one nostril, 4 mg and 8 mg nasal sprays in each nostril, and a 0.4 mg intramuscular injection over a 6-hour period.*

FDA Label Image

Figure 1 (b) (2y2 Figure 1 (b))

A line graph showing naloxone plasma concentration (ng/mL) over 1 hour postdose for different naloxone administration methods including nasal sprays with varying doses and concentrations and a 0.4 mg intramuscular injection. The graph compares plasma levels of 2 mg and 4 mg nasal sprays in one or both nostrils and 8 mg nasal spray, depicting concentration changes over time.*

FDA Label Image

Step 3 (2y2 Step 3)

An instructional diagram showing a hand holding a nasal spray device. The diagram labels two parts of the device: the nozzle and the plunger.*

FDA Label Image

Step 4 (2y2 Step 4)

An instructional black and white illustration showing the administration of a nasal spray to a person lying down. One hand supports the person's head while the other hand inserts the nasal spray applicator into the nostril, demonstrating use of a nasal spray delivery method.*

FDA Label Image

Step 5 (2y2 Step 5)

An instructional illustration showing a hand holding a nasal spray device, with the nozzle inserted into a nostril and spray droplets depicted exiting the nozzle, demonstrating the proper use of a nasal spray.*

FDA Label Image

Step 7 (2y2 Step 7)

An instructional illustration showing a person lying in a recovery position on their side. Labels indicate the hand supports the head and a knee stops the body from rolling onto the stomach, demonstrating safe positioning.*

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure diagram of naloxone hydrochloride, illustrating its molecular arrangement including hydroxyl groups, a nitrogen atom, and chloride.*

FDA Label Image

Step 2 (Image 01)

An instructional illustration showing hands demonstrating the use of a nasal spray device. The image emphasizes proper handling of the device, likely for administering NALOXONE HYDROCHLORIDE nasal spray.*

FDA Label Image

Step1-image1 (Image 02)

An illustration showing the NALOXONE HYDROCHLORIDE HCl 4 mg nasal spray packaging and instructions for use. The image depicts hands holding a small product carton and the nasal spray device, demonstrating how to prepare or use the nasal spray. The packaging displays the product name, strength, and labeler Proficient Rx LP.*

FDA Label Image

71205-707-02 (Image 04)

Label for Naloxone HCl 4 mg nasal spray by Proficient Rx LP, NDC 71205-707-02. It states each 0.1 mL contains 4 mg naloxone hydrochloride (3.6 mg naloxone equivalent) in purified water. The label includes usage instructions emphasizing nasal use only, storage below 77°F, and safety warnings to keep out of children's reach. Manufacturer is Perrigo, Israel.*

FDA Label Image

Step 1 (Quick Start Guide Step 1)

An instructional illustration showing a person kneeling beside another person lying on the ground. The kneeling individual appears to be supporting the patient's head and neck, indicative of a first aid or emergency response posture.*

FDA Label Image

Step 2 Image 2 (Quick Start Guide Step 2 Image 2)

An instructional illustration showing how to use the nasal spray device for NALOXONE HYDROCHLORIDE 4 mg/0.1 mL spray. The first panel labels the nozzle and plunger of the spray device held in a hand. The second panel shows a person lying down with the spray positioned near the nostril. The third panel depicts the spray being administered into the nostril with medication being released from the nozzle.*

FDA Label Image

Step 3 (Quick Start Guide Step 3)

An instructional illustration showing a person positioned on their side with one hand supporting their head and a knee placed to prevent rolling onto the stomach. Labels identify the hand supporting the head and the knee stopping the body from rolling onto the stomach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.